GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q3 2020

SEC EDGAR SourceSEC Filings

Top Holdings45 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

TENET HEALTHCARE CORP

19.8M$484.4M15.2%$17.93+30.97%
8 qtrssince 2018-Q4
Unchanged
0
TAKTAK
ADR

TAKEDA PHARMACEUTIC-SP ADR

16.8M$299.5M9.4%$18.82-9.75%
7 qtrssince 2019-Q1
Increased
63

BAUSCH HEALTH COS INC

15M$232.4M7.3%$22.43-33.66%
8 qtrssince 2018-Q4
Decreased
0

THE CIGNA GROUP

1.3M$221.9M7.0%$158.72-3.45%
8 qtrssince 2018-Q4
Increased
61

HCA HOLDINGS INC

1.6M$204.3M6.4%$119.49-3.89%
8 qtrssince 2018-Q4
Decreased
0

MCKESSON CORP

1.3M$188.7M5.9%$106.42+33.37%
8 qtrssince 2018-Q4
Increased
63

DXC TECHNOLOGY CO

10.2M$182.4M5.7%$48.08-63.19%
8 qtrssince 2018-Q4
Decreased
0
698,442$131.5M4.1%$4.10+87.32%
2 qtrssince 2020-Q2
Decreased
0
HOLXHOLXDelisted

HOLOGIC INC

1.5M$96.4M3.0%$43.06+53.54%
8 qtrssince 2018-Q4
Decreased
0
PARAPARADelisted

PARAMOUNT GLOBAL

3.4M$96.3M3.0%
4 qtrssince 2019-Q4
Decreased
0

MERITOR INC

3.9M$81.1M2.5%
8 qtrssince 2018-Q4
Decreased
0
NUANNUANDelisted

NUANCE COMMUNICATIONS INC

2.4M$79.9M2.5%
8 qtrssince 2018-Q4
Decreased
0

AMERISOURCEBERGEN CORP

819,674$79.4M2.5%$71.04+20.41%
8 qtrssince 2018-Q4
Decreased
0

FMC CORP

694,509$73.6M2.3%$52.60+70.45%
8 qtrssince 2018-Q4
Decreased
0

IQVIA HOLDINGS INC

418,985$66M2.1%$115.32+34.22%
8 qtrssince 2018-Q4
Decreased
0

UNIVERSAL HEALTH SERVICES-B

575,634$61.6M1.9%$97.79+2.13%
8 qtrssince 2018-Q4
Decreased
0

CORTEVA INC

1.7M$48.1M1.5%$25.80+4.45%
4 qtrssince 2019-Q4
Decreased
0

MARRIOTT INTERNATIONAL -CL A

437,717$40.5M1.3%$83.52+7.64%
2 qtrssince 2020-Q2
Decreased
0

BOSTON SCIENTIFIC CORP

1M$39.9M1.3%$32.63+17.10%
3 qtrssince 2020-Q1
Decreased
0

MOLINA HEALTHCARE INC

208,374$38.1M1.2%$144.53+18.87%
3 qtrssince 2020-Q1
Decreased
0
$3.2B
AUM
45
Positions
Q3 2020
Filing
Rating · 3.5
Quarterly Portfolio Change
-2%Q2'19$11B-14%Q3'19$9.5B+20%Q4'19$11.4B-68%Q1'20$3.7B-1%Q2'20$3.6B-12%Q3'20$3.2B
Activity profile
$ moved · Q3'20
New7%Increased10%Decreased72%Exited11%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.1 years
<1Q11%1-4Q29%1-2Y60%2Y+0%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $3.2B across 45 positions as of Q3 2020. Top holdings: THC (15.2%), TAK (9.4%), BHC (7.3%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q3 2020 Summary

Active quarter - 7 new positions, 5 exits, 9 increased. Top move: TAK (INCREASED, conviction 63). Portfolio: $3.2B across 45 positions.

Top holdings by portfolio weight

Total AUM$3B
THC15.20%
TAK9.40%
BHC7.30%
CI6.97%
HCA6.41%
MCK5.92%
DXC5.73%
LABORATORY C4.13%
HOLX3.03%
PARA3.02%
Other2.54%

Portfolio allocation by GICS sector

Sectors8
Healthcare73.07%
Unknown10.59%
Technology6.67%
Basic Materials4.64%
Consumer Cyclical2.77%
Industrials1.53%
Real Estate0.56%
Communication Services0.18%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record72
Conviction49
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PAYMENTS INC
Q2 2025 Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON.COM INC
Q3 2025 Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used